 BOONTON, N.J., June 15, 2021 PRNewswire -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation Nasdaq: SWKH, announced that the company will host a webinar, titled, Key Considerations for HPAPI Oral Drug Product Development. 